Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Introduction to Language of Pathophysiology ll

Introduction to Language of Pathophysiology ll

This lesson explores key terms that describe how diseases progress, their outcomes, and their distribution in populations.Diagnostic tests identify diseases and monitor treatment. These include blood and urine tests, biopsies, imaging (X-ray, MRI), and detection of infectious agents.Remission is a reduction or disappearance of symptoms.Exacerbation refers to the worsening of symptoms, such as increased wheezing during an asthma attack.A precipitating factor triggers an acute episode, while a...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

SIRT1, miR-132 and miR-212 link human longevity to Alzheimer's Disease.

Scientific reports·2018

Same author

Premature primary tooth eruption in cognitive/motor-delayed ADNP-mutated children.

Translational psychiatry·2017

Same author

Premature primary tooth eruption in cognitive/motor-delayed ADNP-mutated children.

Translational psychiatry·2017

Same author

RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining.

Translational psychiatry·2017

Same author

ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy.

Molecular psychiatry·2017

Same author

RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining.

Translational psychiatry·2016

Search research articles

Related Experiment Video

Updated: Jun 10, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

Tau pathology and future therapeutics.

¹Laboratory for Molecular Neuroendocrinology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel. igozes@post.tau.ac.il.

Current Alzheimer Research

|August 4, 2010

Summary

Activity-dependent neuroprotective protein (ADNP) deficiency causes tauopathy, a condition targeted by the drug candidate davunetide. Davunetide shows promise for treating frontotemporal dementia and other neurodegenerative diseases.

Area of Science:

Neuroscience
Pathology
Pharmacology

Background:

Microtubules and tau protein are crucial in healthy brains but implicated in neurodegenerative diseases like Alzheimer's disease (AD).
Tau pathology, including neurofibrillary tangles, is a hallmark of AD and other tauopathies, often correlating with cognitive decline.
While AD features both amyloid plaques and tau tangles, other disorders like Pick's disease are defined by tau inclusions alone.

Purpose of the Study:

To review the role of tau pathology in neurodegenerative diseases, focusing on Alzheimer's disease and tauopathies.
To highlight the potential of activity-dependent neuroprotective protein (ADNP) and its derived drug candidate, davunetide, in combating tau pathology.
To discuss tau as a diagnostic marker and explore therapeutic strategies for tau-related disorders.

More Related Videos

Ole Isacson: Development of New Therapies for Parkinson's Disease

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

Related Experiment Videos

Last Updated: Jun 10, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

Ole Isacson: Development of New Therapies for Parkinson's Disease

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

Main Methods:

Review of existing literature on microtubules, tau pathology, and neurodegenerative diseases.
Presentation of original research findings on the role of ADNP in tauopathy.
Discussion of davunetide as a therapeutic agent targeting tau pathology.

Main Results:

ADNP deficiency is linked to the development of tauopathy.
Davunetide effectively inhibits tauopathy induced by ADNP deficiency.
Tau is presented as a potential diagnostic biomarker for brain disorders.

Conclusions:

Davunetide demonstrates significant therapeutic potential for frontotemporal dementia (FTD) and other intractable neurodegenerative diseases characterized by tau pathology.
The findings support davunetide's advancement as a first-in-class treatment and a prototype for future neurodegenerative disease therapeutics.
Further research and clinical development of davunetide are crucial for addressing the unmet need in treating brain disorders.